Thomson Reuters Corp (TRI.N)

TRI.N on New York Stock Exchange

36.95USD
24 Oct 2014
Price Change (% chg)

$0.82 (+2.27%)
Prev Close
$36.13
Open
$36.20
Day's High
$37.01
Day's Low
$36.20
Volume
214,354
Avg. Vol
164,519
52-wk High
$38.73
52-wk Low
$33.21

TRI.N

Chart for TRI.N

About

Thomson Reuters Corporation (Thomson Reuters) is a provider of information for the world’s businesses and professionals. It is organized in four business units: Financial & Risk, Legal, Tax & Accounting and Intellectual Property & Science. It also has a Global Growth & Operations (GGO) organization, which works across its... (more)

Overall

Beta: 0.85
Market Cap (Mil.): $29,650.95
Shares Outstanding (Mil.): 802.41
Dividend: 0.33
Yield (%): 3.57

Financials

  TRI.N Industry Sector
P/E (TTM): 68.08 56.29 32.37
EPS (TTM): 0.54 -- --
ROI: 1.78 6.42 7.14
ROE: 2.75 7.77 10.46
Search Stocks

Lilly profit plunges as cheaper generics take toll

- Eli Lilly and Co said its quarterly earnings plunged 58 percent, hurt by special charges and generic competition for its Cymbalta depression drug, but it affirmed its full-year profit forecast.

23 Oct 2014

Medtronic sticks by Covidien deal but will use debt, not cash

- U.S. medical equipment maker Medtronic Inc said it would still buy Covidien Plc but would use $16 billion in debt rather than cash held overseas, reacting to new U.S. Treasury guidelines designed to cut the benefits of such "inversion deals."

03 Oct 2014

JPM, others underwrite aggressive Tibco buyout loan - sources

NEW YORK, Oct 3 (IFR) - JP Morgan has teamed up with unregulated lenders to underwrite a highly leveraged buyout financing for the acquisition of business software maker Tibco, which market sources said could contravene regulatory guidelines on risky lending.

03 Oct 2014

UPDATE 1-Financial service provider Markit's IPO raises $1.28 bln

June 18 - Markit Ltd said it priced its initial public offering at $24 per share, valuing the financial information service provider at about $4.3 billion.

18 Jun 2014

Financial service provider Markit's IPO raises $1.2 billion: WSJ

- Markit Ltd priced its initial public offering at $24 per share, valuing the financial information service provider at about $4.3 billion, the Wall Street Journal reported, citing sources.

18 Jun 2014

Medtronic's Covidien deal raises bar for rivals to merge

- Medtronic Inc's $43 billion deal for Dublin-based Covidien Plc should accelerate already intense efforts by medical device rivals to seek merger partners, industry analysts and bankers said on Monday. | Video

16 Jun 2014

Medtronic to buy Covidien for $42.9 billion, rebase in Ireland

- U.S. medical device maker Medtronic Inc said on Sunday it had agreed to buy Covidien Plc for $42.9 billion in cash and stock and move its executive base to Ireland in the latest transaction aiming for lower corporate tax rates abroad.

16 Jun 2014

Medtronic nears $45 billion-plus deal for Covidien: sources

- U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.

14 Jun 2014

UPDATE 1-Markit IPO may value company at about $4.47 bln

June 3 - Financial information service provider Markit Ltd said it expected its IPO to be priced at $23-$25 per share, which could value the company at up to $4.47 billion.

03 Jun 2014

Markit IPO may value company at about $4.47 bln

June 3 - Financial information service provider Markit Ltd said it expected its IPO to be priced at $23-$25 per share, which could value the company at up to $4.47 billion.

03 Jun 2014

Competitors

Earnings vs. Estimates

Search Stocks